Search clinical trials for: QRX003-4% Lotion QAM
Total 2333 results
-
Quoin PharmaceuticalsRecruitingNetherton SyndromeUnited States
-
Quoin PharmaceuticalsRecruitingNetherton SyndromeUnited States
-
University of RostockCompletedOsteoarthritis | Total Knee ArthroplastyGermany
-
University of Colorado, DenverCompleted
-
University of ZurichUniversity Hospital, Basel, Switzerland; University of BernRecruitingFinger Injuries | Tendon Injury - HandSwitzerland
-
Rothman Institute OrthopaedicsEnrolling by invitation
-
University of ChicagoNational Institutes of Health (NIH); University of HoustonNot yet recruitingAutologous Fat Grafting
-
Zafer Cavit Cehreli, DDS, PhDUnknownDental Caries in Children | Dental Caries on Pit and Fissure Surface | Dental LeakageUnited States
-
University of UlmNovartisWithdrawn
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States, Canada, Australia
-
Acorda TherapeuticsCompletedMultiple SclerosisUnited States, Canada
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States, Canada, Australia
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis | Post-Polycythemia Vera | Post-Essential Thrombocythemia MyelofibrosisUnited States, Canada
-
GlaxoSmithKlineActive, not recruitingNeoplasms | Primary Myelofibrosis (PMF) | Post-polycythemia Vera Myelofibrosis (Post-PV MF) | Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)United States, Hungary, Israel, Spain, Taiwan, France, Australia, Germany, Belgium, Canada, Singapore, Korea, Republic of, United Kingdom, Denmark, Austria, Romania, Italy, Bulgaria, Poland, Netherlands
-
M.D. Anderson Cancer CenterGlaxoSmithKlineNot yet recruiting
-
Federal University of PelotasCompleted
-
GlaxoSmithKlineNo longer availablePrimary Myelofibrosis | Myelofibrosis
-
Sierra Oncology, Inc.TerminatedPolycythemia Vera | Essential ThrombocythemiaUnited States, France, Germany, Canada, Australia
-
Sierra Oncology LLC - a GSK companyCompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States, France, Canada, Germany, Australia
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post-Essential Thrombocythemia MyelofibrosisUnited States, France, Germany, Spain, Israel, Bulgaria, Romania, Japan, Taiwan, Korea, Republic of, Australia, Belgium, Canada, Netherlands, Singapore, Poland, Hungary, Denmark, Sweden, United Kingdom, Czechia, Austria
-
Sierra Oncology LLC - a GSK companyCompletedPrimary Myelofibrosis (PMF) | Post-polycythemia Vera (Post-PV) Myelofibrosis | Postessential Thrombocythemia (Post-ET) MyelofibrosisUnited States, Canada
-
Coordinación de Investigación en Salud, MexicoCompleted
-
FDA Office of Orphan Products DevelopmentCompletedGuillain-Barre SyndromeUnited States
-
Institut National de la Recherche AgronomiqueCentre de Recherche en Nutrition Humaine d'AuvergneCompleted
-
Novartis PharmaceuticalsRecruitingFLT3-mutated Acute Myeloid LeukemiaKorea, Republic of, Germany, Italy, Turkey, Czechia, Jordan, Slovenia, Austria, Poland, Japan, Russian Federation, United States, Greece
-
Sierra Oncology, Inc.TerminatedRelapsed Metastatic KRAS-Mutated Non-Small Cell Lung CancerUnited States
-
Acorda TherapeuticsCompleted
-
Sierra Oncology, Inc.TerminatedRelapsed/Refractory Metastatic Pancreatic Ductal AdenocarcinomaUnited States
-
PfizerTerminatedAlzheimer DiseaseUnited States, Colombia, Korea, Republic of, Russian Federation, Japan, Hong Kong, South Africa, Poland, Chile, Romania, Mexico, Argentina, New Zealand
-
Sierra Oncology, Inc.TerminatedEGFR Mutated EGFR TKI Naive Metastatic NSCLCUnited States
-
Kessler FoundationNational Institute on Disability, Independent Living, and Rehabilitation... and other collaboratorsCompletedSpinal Cord InjuryUnited States
-
John ElfarUniversity of ArizonaActive, not recruiting
-
Acorda TherapeuticsCompleted
-
Karyopharm Therapeutics IncNot yet recruitingMyelofibrosis | Moderate Thrombocytopenia
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedEstrogen Receptor-positive Breast Cancer | Ductal Breast Carcinoma in SituUnited States
-
University of RochesterWithdrawnProstate DiseaseUnited States
-
Shanghai Miracogen Inc.RecruitingRecurrent or Metastatic Nasopharyngeal CarcinomaChina
-
Institut National de Recherche pour l'Agriculture...Centre de Recherche en Nutrition Humaine d'AuvergneCompletedColorectal CancerFrance
-
Sierra Oncology, Inc.CompletedPrimary Myelofibrosis (PMF) | Post-essential Thrombocythemia Myelofibrosis (Post-ET MF) | Post-polycythemia Vera (Post-PV)United States, Canada, France, Italy, Germany, Spain, Israel, United Kingdom
-
Ain Shams UniversityCompletedDiabetes Mellitus, Type 1 | NASHEgypt
-
Dexa Medica GroupCompleted
-
Acorda TherapeuticsCompletedMultiple SclerosisUnited States, Canada
-
Acorda TherapeuticsCompleted
-
Ganzhou Hemay Pharmaceutical Co., LtdRecruitingBehçet's DiseaseChina
-
Tianjin Hemay Pharmaceutical Co., LtdTerminated
-
University of MichiganDepartment of Health and Human ServicesCompleted
-
McNeil ABCompletedTobacco DependenceRussian Federation
-
Coordinación de Investigación en Salud, MexicoActive, not recruitingSpinal Cord Injuries | ChronicMexico
-
Shanghai Zhongshan HospitalWest China Hospital; Tongji Hospital; Anhui Provincial HospitalUnknownHepatocellular Carcinoma (HCC)China
-
Acorda TherapeuticsCompletedMultiple SclerosisUnited States, Canada